CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear
Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a month of plants change the course of blood cancer?
Disease control Recruiting nowThis study is testing whether switching to a strict whole-food, plant-based diet for four weeks can affect the immune system and slow down early-stage chronic lymphocytic leukemia (CLL), a type of blood cancer. Researchers will enroll 50 people with early CLL who are not yet on t…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Pioneering trial tests 'Off-the-Shelf' bone marrow from deceased donors
Disease control Recruiting nowThis early-stage study is testing the safety and feasibility of using bone marrow from deceased donors for patients with various blood cancers like leukemia and lymphoma. The goal is to see if this type of transplant can help patients when a living donor isn't available. Research…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough blood cancers: first patients test experimental drug
Disease control Recruiting nowThis is the first study in people testing a new drug called ZE50-0134 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The main goals are to find a safe dose and see how the body h…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for blood cancer patients: trial tests better protection after transplants
Disease control Recruiting nowThis study aims to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Researchers are comparing two new drug combinations against the current standard …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists track blood cancers for clues to future cures
Knowledge-focused Recruiting nowThis study aims to learn how certain blood cancers develop and change over time. Researchers will follow up to 1,000 adults who have been diagnosed with these conditions, collecting blood and tissue samples regularly. The goal is to understand the biology of these diseases to hel…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC